跳至主要内容
临床试验/ISRCTN60691705
ISRCTN60691705已完成未知

RIVET: Re-inventing Influenza Vaccine Efficacy Trials

Vaccitech0 个研究点目标入组 46 人开始时间: 2016年10月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Vaccitech
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Willing and has capacity to provide written informed consent for participation in the study and to comply with all study requirements (in the Investigator’s opinion)
  • 2. Male or female adults, aged 65 years or above
  • 3. Eligible to receive seasonal influenza vaccine

排除标准

  • 1. Ongoing terminal illness with a life expectancy of <6 months
  • 2. Any other significant disease, which, in the opinion of the Investigators, would put at risk their ability to comply with the study procedures
  • 3. Have already received the annual seasonal influenza vaccine (Phase 2 participants only)

研究者

发起方
Vaccitech

相似试验

进行中(未招募)
1 期
A Study Promoting the Influenza Response in the ElderlyThe trial is aimed to improve the efficiency of the seasonal influenza vaccine. Healthy volunteers who are positive for cytomegalovirus (CMV) will be recruited and given anti-viral treatment. We hypothesise that this will reduce their viral load and thereby reduce the proportion of T cells committed to CMV. This will then facilitate the development of an optimal response against the influenza vaccine.
EUCTR2011-000092-13-GB
尚未招募
不适用
Efficacy and effectiveness of influenza vaccine and pneumococcal conjugated vaccine &#45; 13 (PCV13) in patients with chronic kidney diseaseInfluenza vaccine13&#45valent pneumococcal vaccinechronic kidney diseaseschronic kidney diseasepneumonia
TCTR20160609002Queen Saovabha Memorial Institute&#44; the Thai Redcross society1,584
已完成
3 期
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.Influenza
NCT02255279Novartis Vaccines287
已完成
4 期
Evaluation of efficacy and safety of an enhanced influenza vaccination schedule in immunocompromised children undergoing treatment for cancer.Influenza infectionResponse to influenza vaccineCancer - Children's - BrainCancer - Children's - Leukaemia & LymphomaCancer - Children's - OtherInfection - Other infectious diseasesInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesPublic Health - Other public healthCancer
ACTRN12620000548932CAHS78
已完成
不适用
Immunogenicity and safety of conventional influenza vaccine in patients with type 2 diabetesCertain infectious and parasitic diseases
KCT0001423Transgovernmental Enterprise for Pandemic Influenza in Korea236